Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?
about
Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stressExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Defective mitophagy driven by dysregulation of rheb and KIF5B contributes to mitochondrial reactive oxygen species (ROS)-induced nod-like receptor 3 (NLRP3) dependent proinflammatory response and aggravates lipotoxicityLoss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance.Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome.Sterol Regulatory Element-Binding Protein-1c Regulates Inflammasome Activation in Gingival Fibroblasts Infected with High-Glucose-Treated Porphyromonas gingivalis.Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes.SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.Inflammasomes link vascular disease with neuroinflammation and brain disorders.Study of the NLRP3 inflammasome component genes and downstream cytokines in patients with type 2 diabetes mellitus with carotid atherosclerosis.The intra- and extracellular functions of ASC specks.Nucleotide-Binding Domain Leucine-Rich Repeat Containing Proteins and Intestinal Microbiota: Pivotal Players in Colitis and Colitis-Associated Cancer Development.Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease
P2860
Q27022552-5F946004-76E7-4833-8D80-86C92893E400Q28079163-20EF4363-E17D-41CB-88CA-ABC85156FDA4Q28575583-CBCFBE4D-F397-4C96-9609-5BAA5F232FB1Q36119524-4BECF3F0-13F8-4AAD-989A-343F32CCBC13Q37177528-5323CC15-8751-4E83-A6D4-730DEB799DA9Q37531487-6E5EE07C-F6CA-4663-BE91-7257EC002363Q37568237-2CE0B396-CEEB-48B1-8D76-465A4F31F3D5Q38288267-7E294EB0-5904-4717-B637-D8A23C725763Q38916890-CB809FCA-3099-4923-B08C-922C0E2873C2Q47131367-8C56CE99-EBFB-4553-88F5-91BECFF06BACQ47285910-90930915-D0D1-484D-8A5C-7A30A8A3D5C5Q54963731-2DD06DDD-7A45-4E4D-AB9E-D03D586FA7F1Q57816569-AA0EB73A-683A-422B-86E1-177E627617F3
P2860
Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?
@ast
Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?
@en
type
label
Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?
@ast
Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?
@en
prefLabel
Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?
@ast
Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?
@en
P2860
P356
P1433
P1476
Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?
@en
P2093
Vishwa Deep Dixit
P2860
P356
10.2337/DB12-1115
P407
P577
2013-01-01T00:00:00Z